Bluejay Diagnostics Announces $1.59 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

<p>ACTON, Mass., Aug. 25, 2023 (GLOBE NEWSWIRE) — Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company developing rapid diagnostics on its Symphony platform to improve patient outcomes in critical care settings, today announced that it has entered into a definitive agreement for the purchase and sale of 216,000 shares of […]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/bluejay-diagnostics-announces-1-59-million-registered-direct-offering-priced-at-the-market-under-nasdaq-rules/">Bluejay Diagnostics Announces $1.59 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>